Short description
Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.
Description
Boston Therapeutics is a pharmaceutical company focused on the development, manufacturing and commercialization of novel compounds to address unmet medical needs in the areas of diabetes and inflammatory diseases. The Company's products are based on the platform of applied complex carbohydrate drug design in pharmaceutical and over-the-counter products.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Lawrence, Massachusetts, United States, North America
Founded on
January 1, 2009
Exited on
February 8, 2010
Went public on
February 8, 2010
Stock symbol
BTHE
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess
Sign in for full access
Founders
David Platt